Staphylococcus aureus infection induces protein A-mediated immune evasion in humans

Journal of Experimental Medicine

Volumn 211, Issue 12, 2014, Pages 2331-2339

  Pauli, Noel T ^a   Kim, Hwan Keun ^a   Falugi, Fabiana ^a   Huang, Min ^a   Dulac, John ^a   Dunand, Carole Henry ^a   Zheng, Nai Ying ^a   Kaur, Kaval ^a   Andrews, Sarah F ^a   Huang, Yunping ^a   DeDent, Andrea ^a   Frank, Karen M ^a   Charnot Katsikas, Angella ^a   Schneewind, Olaf ^a   Wilson, Patrick C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BACTERIAL ANTIGEN; IMMUNOGLOBULIN IDIOTYPE; MONOCLONAL ANTIBODY; PROTEIN A; STAPHYLOCOCCUS VACCINE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN VARIABLE REGION; STAPHYLOCOCCUS PROTEIN A; VIRULENCE FACTOR;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; B LYMPHOCYTE; BACTERIAL VIRULENCE; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; MEMORY CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PLASMA CELL; PROTEIN EXPRESSION; RECURRENT INFECTION; STAPHYLOCOCCUS INFECTION; DNA SEQUENCE; FLOW CYTOMETRY; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PHYSIOLOGY; PRE B LYMPHOCYTE; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; FLOW CYTOMETRY; GERMINAL CENTER; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PLASMA CELLS; PRECURSOR CELLS, B-LYMPHOID; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84911940230     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20141404     Document Type: Article

References (30)

1. Bagnoli, F., S. Bertholet, and G. Grandi. 2012. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Microbiol. 2:16.
2. Björk, I., B.-Å. Petersson, and J. Sjöquist. 1972. Some physiochemical properties of protein A from Staphylococcus aureus. Eur. J. Biochem. 29:579-584.
3. Chang, F.Y., J.E. Peacock Jr., D.M. Musher, P. Triplett, B.B. MacDonald, J.M. Mylotte, A. O'Donnell, M.M. Wagener, and V.L. Yu. 2003. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 82:333-339. http://dx.doi.org/10.1097/01.md.0000091184.93122.09
4. Colque-Navarro, P., G. Jacobsson, R. Andersson, J.-I. Flock, and R. Möllby. 2010. Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin. Vaccine Immunol. 17:1117-1123. http://dx.doi.org/10.1128/CVI.00506-09
5. Cook, G.P., and I.M. Tomlinson. 1995. The human immunoglobulin VH repertoire. Immunol. Today. 16:237-242. http://dx.doi.org/10.1016/0167-5699(95)80166-9
6. Dryla, A., S. Prustomersky, D. Gelbmann, M. Hanner, E. Bettinger, B. Kocsis, T. Kustos, T. Henics, A. Meinke, and E. Nagy. 2005. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab. Immunol. 12:387-398.
7. Falugi, F., H.K. Kim, D.M. Missiakas, and O. Schneewind. 2013. Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio. 4:e00575-e13.
8. Forsgren, A. 1970. Significance of protein a production by staphylococci. Infect. Immun. 2:672-673.
9. Gitlin, A.D., Z. Shulman, and M.C. Nussenzweig. 2014. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature. 509:637-640. http://dx.doi.org/10.1038/nature13300
10. Gjertsson, I., O.H. Hultgren, M. Stenson, R. Holmdahl, and A. Tarkowski. 2000. Are B lymphocytes of importance in severe Staphylococcus aureus infections? Infect. Immun. 68:2431-2434. http://dx.doi.org/10.1128/IAI.68.5.2431-2434.2000
11. Goodyear, C.S., and G.J. Silverman. 2003. Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin. J. Exp. Med. 197:1125-1139. http://dx.doi.org/10.1084/jem.20020552
12. Graille, M., E.A. Stura, A.L. Corper, B.J. Sutton, M.J. Taussig, J.B. Charbonnier, and G.J. Silverman. 2000. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc. Natl. Acad. Sci. USA. 97:5399-5404. http://dx.doi.org/10.1073/pnas.97.10.5399
13. Hermos, C.R., P. Yoong, and G.B. Pier. 2010. High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clin. Infect. Dis. 51:1138-1146. http://dx.doi.org/10.1086/656742
14. Kim, H.K., A.G. Cheng, H.-Y. Kim, D.M. Missiakas, and O. Schneewind. 2010. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J. Exp. Med. 207:1863-1870. http://dx.doi.org/10.1084/jem.20092514
15. Klevens, R.M., M.A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L.H. Harrison, R. Lynfield, G. Dumyati, J.M. Townes, et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 298:1763-1771. http://dx.doi.org/10.1001/jama.298.15.1763
16. Kreisel, K., K. Boyd, P. Langenberg, and M.-C. Roghmann. 2006. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn. Microbiol. Infect. Dis. 55:179-184. http://dx.doi.org/10.1016/j.diagmicrobio.2006.01.021
17. Li, G.-M., C. Chiu, J. Wrammert, M. McCausland, S.F. Andrews, N.-Y. Zheng, J.-H. Lee, M. Huang, X. Qu, S. Edupuganti, et al. 2012. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. USA. 109:9047-9052.
18. Lu, D.R., Y.-C. Tan, S. Kongpachith, X. Cai, E.A. Stein, T.M. Lindstrom, J. Sokolove, and W.H. Robinson. 2014. Identifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts. Clin. Immunol. 152:77-89. http://dx.doi.org/10.1016/j.clim.2014.02.010
19. Potter, K.N., Y. Li, and J.D. Capra. 1996. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs. J. Immunol. 157:2982-2988.
20. Sasano, M., D.R. Burton, and G.J. Silverman. 1993. Molecular selection of human antibodies with an unconventional bacterial B cell antigen. J. Immunol. 151:5822-5839.
21. Silverman, G.J., M. Sasano, and S.B. Wormsley. 1993. Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen. J. Immunol. 151:5840-5855.
22. Smith, K., L. Garman, J. Wrammert, N.-Y. Zheng, J.D. Capra, R. Ahmed, and P.C. Wilson. 2009. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4:372-384. http://dx.doi.org/10.1038/nprot.2009.3
23. Smith, K., J.J. Muther, A.L. Duke, E. McKee, N.-Y. Zheng, P.C. Wilson, and J.A. James. 2013. Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology. 218:745-754. http://dx.doi.org/10.1016/j.imbio.2012.08.278
24. Verkaik, N.J., C.P. de Vogel, H.A. Boelens, D. Grumann, T. Hoogenboezem, C. Vink, H. Hooijkaas, T.J. Foster, H.A. Verbrugh, A. van Belkum, and W.J.B. van Wamel. 2009. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J. Infect. Dis. 199:625-632. http://dx.doi.org/10.1086/596743
25. Wertheim, H.F.L., M.C. Vos, A. Ott, A. van Belkum, A. Voss, J.A.J.W. Kluytmans, P.H.J. van Keulen, C.M.J.E. Vandenbroucke-Grauls, M.H.M. Meester, and H.A. Verbrugh. 2004. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 364:703-705. http://dx.doi.org/10.1016/S0140-6736(04)16897-9
26. Wisplinghoff, H., T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317. http://dx.doi.org/10.1086/421946
27. Wrammert, J., K. Smith, J. Miller, W.A. Langley, K. Kokko, C. Larsen, N.-Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of highaffinity human monoclonal antibodies against influenza virus. Nature. 453:667-671. http://dx.doi.org/10.1038/nature06890
28. Wrammert, J., D. Koutsonanos, G.-M. Li, S. Edupuganti, J. Sui, M. Morrissey, M. McCausland, I. Skountzou, M. Hornig, W.I. Lipkin, et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181-193. http://dx.doi.org/10.1084/jem.20101352
29. Xu, M., V. Hadinoto, R. Appanna, K. Joensson, Y.X. Toh, T. Balakrishnan, S.H. Ong, L. Warter, Y.S. Leo, C.-I. Wang, and K. Fink. 2012. Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes. J. Immunol. 189:5877-5885. http://dx.doi.org/10.4049/jimmunol.1201688
30. Zecconi, A., and F. Scali. 2013. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. Immunol. Lett. 150:12-22. http://dx.doi.org/10.1016/j.imlet.2013.01.004